Patents by Inventor Nayna Govind

Nayna Govind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for inhalation
    Patent number: 11311558
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: April 26, 2022
    Assignee: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • Composition for Inhalation
    Publication number: 20210069215
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: March 27, 2020
    Publication date: March 11, 2021
    Applicant: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • Composition for Inhalation
    Publication number: 20190216828
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: August 22, 2018
    Publication date: July 18, 2019
    Applicant: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • Composition for inhalation
    Patent number: 10166247
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: January 1, 2019
    Assignee: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • Composition for Inhalation
    Publication number: 20170368078
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: February 8, 2017
    Publication date: December 28, 2017
    Inventors: Nayna Govind, Maria Marlow
  • Composition for Inhalation
    Publication number: 20160022703
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: March 2, 2015
    Publication date: January 28, 2016
    Inventors: Nayna Govind, Maria Marlow
  • COMPOSITION FOR INHALATION
    Publication number: 20140286878
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: October 18, 2013
    Publication date: September 25, 2014
    Applicant: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • Composition for inhalation
    Patent number: 8575137
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: November 5, 2013
    Assignee: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • COMPOSITION FOR INHALATION
    Publication number: 20120216802
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: March 5, 2012
    Publication date: August 30, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Nayna Govind, Maria Marlow
  • Composition for inhalation
    Patent number: 8143239
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: March 27, 2012
    Assignee: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • COMPOSITION FOR INHALATION
    Publication number: 20100275913
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: May 28, 2010
    Publication date: November 4, 2010
    Inventors: Nayna Govind, Maria Marlow
  • Composition for inhalation
    Patent number: 7759328
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: July 20, 2010
    Assignee: AstraZeneca AB
    Inventors: Nayna Govind, Maria Marlow
  • Steroid solution aerosol products with enhanced chemical stability
    Publication number: 20050220717
    Abstract: A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids.
    Type: Application
    Filed: February 22, 2005
    Publication date: October 6, 2005
    Inventors: Zheng Wu, Nayna Govind, Peter Johnson
  • Composition for inhalation
    Publication number: 20050089478
    Abstract: The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.
    Type: Application
    Filed: January 29, 2003
    Publication date: April 28, 2005
    Inventors: Nayna Govind, Maria Marlow
  • Process for making chemically stable C-17/21 OH 20-ketosteroid aerosol products
    Publication number: 20040033201
    Abstract: A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids.
    Type: Application
    Filed: July 30, 2003
    Publication date: February 19, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Zheng Z. Wu, Nayna Govind, Peter R. Johnson
  • Process for making chemically stable C-17/21 OH 20-ketosteroid aerosol products
    Patent number: 6610273
    Abstract: A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: August 26, 2003
    Assignee: 3M Innovative Properties Company
    Inventors: Zheng Z. Wu, Nayna Govind, Peter R. Johnson
  • C-17/21 OH 20-ketostroid solution aerosol products with enhanced chemical stability
    Publication number: 20020071810
    Abstract: A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids.
    Type: Application
    Filed: October 4, 2001
    Publication date: June 13, 2002
    Applicant: 3M Innovative Properties Company
    Inventors: Zheng Z. Wu, Nayna Govind, Peter R. Johnson
  • C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
    Patent number: 6315985
    Abstract: A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: November 13, 2001
    Assignee: 3M Innovative Properties Company
    Inventors: Zheng Z. Wu, Nayna Govind, Peter R. Johnson
  • Medicinal inhalation aerosol formulations containing budesonide
    Patent number: 6039932
    Abstract: A pharmaceutical aerosol formulation, suitable for administration by oral or nasal inhalation, containing a suspension of particulate budesonide, hydrofluoroalkane propellant and, optionally, additional hydrofluoroalkane propellants, surfactant selected from oleic acid, sorbitan oleates and lecithin, and adjuvant have a Kauri-butanol value of at least 10.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: March 21, 2000
    Assignee: 3M Innovative Properties Company
    Inventors: Nayna Govind, Philip A. Jinks, Danna L. Ross, Gary H. Ward